Legal Opinion
Biodelivery Scis. Int'l, Inc. v. Aquestive Therapeutics, Inc.
Court of Appeals for the Federal Circuit
Decided August 29, 2019No. 2019-1643; 2019-1644; 2019-1645PublishedCited by 3 opinions
1Opinion of the Court
Reyna, Circuit Judge.
ORDER
Aquestive Therapeutics, Inc. moves to dismiss these appeals on the basis that our review is barred by 35 U.S.C. § 314 (d). BioDelivery Sciences International, Inc. opposes the motion. Having considered the parties' arguments, we grant the motion and dismiss these appeals.
BACKGROUND
In October 2014, BioDelivery filed three petitions for inter partes review ("IPR") of U.S. Patent No. 8,765,167 . The petitions contained a combined total of seventeen grounds. The petition in IPR2015-00165 included seven grounds, the petition in IPR2015-00168 included five grounds, and the…
2Cases cited10 opinions
- SAS Institute Inc. v. IancuSupreme Court of the United States · 2018
- Cuozzo Speed Technologies, LLC v. LeeSupreme Court of the United States · 2016
- Tokyo Kikai Seisakusho, Ltd. v. United StatesCourt of Appeals for the Federal Circuit · 2008
- PGS GEOPHYSICAL AS v. IANCUCourt of Appeals for the Federal Circuit · 2018
- Wi-Fi One, LLC v. Broadcom CorporationCourt of Appeals for the Federal Circuit · 2018
5 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Atlanta Gas Light Company v. Bennett Regulator Guards, Inc.Court of Appeals for the Federal Circuit · 2022
- Atlanta Gas Light Company v. Bennett Regulator Guards, Inc.Court of Appeals for the Federal Circuit · 2022
- Sling Tv, L.L.C. v. Realtime Adaptive StreamingCourt of Appeals for the Federal Circuit · 2021